BCP
BSX icon

BSN Capital Partners’s Boston Scientific BSX Stock Holding History

BSN Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-629,000
Closed -$60.1M – 33
2026
Q1 		$60.1M Buy
629,000
+129,000
+26% +$10.3M 1.53% 11
2025
Q4 		$50.1M Buy
+500,000
New +$49M 2.36% 11

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BSN Capital Partners's BSX Position: Q2 2026 in Review

BSN Capital Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 629,000 shares — an estimated $60.1M sold.

BSN Capital Partners first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $60.1M in Q1 2026. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • BSN Capital Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • BSN Capital Partners sold 629,000 Boston Scientific shares in Q2 2026, an estimated $60.1M.
  • BSN Capital Partners first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • BSN Capital Partners's Boston Scientific position peaked at $60.1M in Q1 2026.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BSN Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.